Biopharmaceutical CMO Global Market Report 2025

Biopharmaceutical CMO Global Market Report 2025

Including: 1) By Product: Biologics; Biosimilars2) By Source: Mammalian; Non-Mammalian3) By Service: Manufacturing; Fill And Finish Operations; Analytical And QC Studies; PackagingCovering: Lonza Group AG; Fujifilm Diosynth Biotechnologies USA Inc.; Thermo Fisher Scientific Inc.; Samsung Biologics; WuXi AppTec


Biopharmaceutical CMO Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on biopharmaceutical cmo market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.
Description:

Where is the largest and fastest growing market for biopharmaceutical cmo ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The biopharmaceutical cmo market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope

Markets Covered:1) By Product: Biologics; Biosimilars

2) By Source: Mammalian; Non-Mammalian

3) By Service: Manufacturing; Fill And Finish Operations; Analytical And QC Studies; Packaging

Subsegments:

1) By Biologics: Monoclonal Antibodies; Recombinant Proteins; Vaccines; Cell and Gene Therapies

2) By Biosimilars: Biosimilar Monoclonal Antibodies; Biosimilar Recombinant Proteins; Biosimilar Insulins; Biosimilar Growth Hormones

Companies Mentioned: Lonza Group AG; Fujifilm Diosynth Biotechnologies USA Inc.; Thermo Fisher Scientific Inc.; Samsung Biologics; WuXi AppTec

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery format: PDF, Word and Excel Data Dashboard.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.


1. Executive Summary
2. Biopharmaceutical CMO Market Characteristics
3. Biopharmaceutical CMO Market Trends And Strategies
4. Biopharmaceutical CMO Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
5. Global Biopharmaceutical CMO Growth Analysis And Strategic Analysis Framework
5.1. Global Biopharmaceutical CMO PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Biopharmaceutical CMO Market Growth Rate Analysis
5.4. Global Biopharmaceutical CMO Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Biopharmaceutical CMO Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Biopharmaceutical CMO Total Addressable Market (TAM)
6. Biopharmaceutical CMO Market Segmentation
6.1. Global Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Biologics
Biosimilars
6.2. Global Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Mammalian
Non-Mammalian
6.3. Global Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Manufacturing
Fill And Finish Operations
Analytical And QC Studies
Packaging
6.4. Global Biopharmaceutical CMO Market, Sub-Segmentation Of Biologics, By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Monoclonal Antibodies
Recombinant Proteins
Vaccines
Cell and Gene Therapies
6.5. Global Biopharmaceutical CMO Market, Sub-Segmentation Of Biosimilars, By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Biosimilar Monoclonal Antibodies
Biosimilar Recombinant Proteins
Biosimilar Insulins
Biosimilar Growth Hormones
7. Biopharmaceutical CMO Market Regional And Country Analysis
7.1. Global Biopharmaceutical CMO Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Biopharmaceutical CMO Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Biopharmaceutical CMO Market
8.1. Asia-Pacific Biopharmaceutical CMO Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Biopharmaceutical CMO Market
9.1. China Biopharmaceutical CMO Market Overview
9.2. China Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Biopharmaceutical CMO Market
10.1. India Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Biopharmaceutical CMO Market
11.1. Japan Biopharmaceutical CMO Market Overview
11.2. Japan Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Biopharmaceutical CMO Market
12.1. Australia Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Biopharmaceutical CMO Market
13.1. Indonesia Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Biopharmaceutical CMO Market
14.1. South Korea Biopharmaceutical CMO Market Overview
14.2. South Korea Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Biopharmaceutical CMO Market
15.1. Western Europe Biopharmaceutical CMO Market Overview
15.2. Western Europe Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Biopharmaceutical CMO Market
16.1. UK Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Biopharmaceutical CMO Market
17.1. Germany Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Biopharmaceutical CMO Market
18.1. France Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Biopharmaceutical CMO Market
19.1. Italy Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Biopharmaceutical CMO Market
20.1. Spain Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Biopharmaceutical CMO Market
21.1. Eastern Europe Biopharmaceutical CMO Market Overview
21.2. Eastern Europe Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Biopharmaceutical CMO Market
22.1. Russia Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Biopharmaceutical CMO Market
23.1. North America Biopharmaceutical CMO Market Overview
23.2. North America Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Biopharmaceutical CMO Market
24.1. USA Biopharmaceutical CMO Market Overview
24.2. USA Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Biopharmaceutical CMO Market
25.1. Canada Biopharmaceutical CMO Market Overview
25.2. Canada Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Biopharmaceutical CMO Market
26.1. South America Biopharmaceutical CMO Market Overview
26.2. South America Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Biopharmaceutical CMO Market
27.1. Brazil Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Biopharmaceutical CMO Market
28.1. Middle East Biopharmaceutical CMO Market Overview
28.2. Middle East Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Biopharmaceutical CMO Market
29.1. Africa Biopharmaceutical CMO Market Overview
29.2. Africa Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Biopharmaceutical CMO Market Competitive Landscape And Company Profiles
30.1. Biopharmaceutical CMO Market Competitive Landscape
30.2. Biopharmaceutical CMO Market Company Profiles
30.2.1. Lonza Group AG Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Fujifilm Diosynth Biotechnologies USA Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Samsung Biologics Overview, Products and Services, Strategy and Financial Analysis
30.2.5. WuXi AppTec Overview, Products and Services, Strategy and Financial Analysis
31. Biopharmaceutical CMO Market Other Major And Innovative Companies
31.1. Catalent, Inc.
31.2. Rentschler Biopharma SE
31.3. Boehringer Ingelheim
31.4. Recipharm AB
31.5. AGC Biologics
31.6. CMC Biologics
31.7. KBI Biopharma
31.8. Vetter Pharma International GmbH
31.9. Emergent BioSolutions Inc.
31.10. Aenova Group
31.11. Synlogic, Inc.
31.12. MedImmune (AstraZeneca)
31.13. BioLife Sciences
31.14. Bio-Xcellence (Boehringer Ingelheim)
31.15. AbbVie Contract Manufacturing
32. Global Biopharmaceutical CMO Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Biopharmaceutical CMO Market
34. Recent Developments In The Biopharmaceutical CMO Market
35. Biopharmaceutical CMO Market High Potential Countries, Segments and Strategies
35.1 Biopharmaceutical CMO Market In 2029 - Countries Offering Most New Opportunities
35.2 Biopharmaceutical CMO Market In 2029 - Segments Offering Most New Opportunities
35.3 Biopharmaceutical CMO Market In 2029 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings